ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $206,219 (100.0% shares, 0.0% debt)

Holdings (9)

BEAM BEAM THERAPEUTICS INC. 43.0%

Value ($000) $88,669 Shares 4,540,132 Est. Cost $24.56 Unrealized +6.7%

MAZE MAZE THERAPEUTICS, INC. 22.0%

Value ($000) $45,362 Shares 4,120,053 Est. Cost $12.04 Unrealized 0.0%

RAPP RAPPORT THERAPEUTICS, INC. 18.2%

Value ($000) $37,548 Shares 3,728,738 Est. Cost $23.15 Unrealized -43.9%

ERAS ERASCA, INC. 7.3%

Value ($000) $15,146 Shares 11,055,554 Est. Cost $17.12 Unrealized -90.0%

— VERVE THERAPEUTICS, INC. 4.4%

Value ($000) $9,120 Shares 2,008,809 Est. Cost $36.87 Unrealized —

GOSS GOSSAMER BIO, INC. 4.3%

Value ($000) $8,781 Shares 8,055,916 Est. Cost $1.15 Unrealized +0.3%

— UNITY BIOTECHNOLOGY, INC. 0.5%

Value ($000) $1,045 Shares 1,004,817 Est. Cost $0.40 Unrealized —

QTTB Q32 BIO INC. 0.3%

Value ($000) $532 Shares 320,482 Est. Cost $13.78 Unrealized -80.5%

— CERO THERAPEUTICS HOLDINGS, INC. 0.0%

Value ($000) $16 Shares 22,102 Est. Cost $0.73 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BEAM	BEAM THERAPEUTICS INC.	4,540,132	$88,669	43.0%	$24.56	+6.7%	COM	07373V105
MAZE	MAZE THERAPEUTICS, INC.	4,120,053	$45,362	22.0%	$12.04	0.0%	COM	578784100
RAPP	RAPPORT THERAPEUTICS, INC.	3,728,738	$37,548	18.2%	$23.15	-43.9%	COM	75383L102
ERAS	ERASCA, INC.	11,055,554	$15,146	7.3%	$17.12	-90.0%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,008,809	$9,120	4.4%	$36.87	—	COM	92539P101
GOSS	GOSSAMER BIO, INC.	8,055,916	$8,781	4.3%	$1.15	+0.3%	COM	38341P102
—	UNITY BIOTECHNOLOGY, INC.	1,004,817	$1,045	0.5%	$0.40	—	COM NEW	91381U200
QTTB	Q32 BIO INC.	320,482	$532	0.3%	$13.78	-80.5%	COM	746964105
—	CERO THERAPEUTICS HOLDINGS, INC.	22,102	$16	0.0%	$0.73	—	COM NEW	71902K303